Key Takeaways C3.ai's Gen AI revenue surged 100% in fiscal 2025, with 66 deployments across 16 industries. Partner-led bookings for C3.ai jumped 419% with 193 deals closed through alliances in fiscal 2025. C3.ai secured a $450M U.S. Air Force deal, boosting its growing federal sector momentum.Innodata (INOD) and C3.ai (AI) are well-known artificial intelligence (AI) focused stocks that cater to the needs of enterprises. While Innodata offers AI data engineering and model training services, C3.ai provides ...

LANCASTER, Pa., July 1, 2025 /PRNewswire/ -- Fulton Financial Corporation ("Fulton") (Nasdaq: FULT) today announced that it will distribute its second quarter 2025 earnings release and accompanying charts on Tuesday, July 15, at approximately 4:30 p.m. Eastern Time.Fulton will host a conference call with analysts on Wednesday, July 16, at 10 a.m. Eastern Time. Curtis J. Myers, Chairman and CEO, will host the call. He will be joined by Rick Kraemer, Senior Executive Vice President and CFO.The link to the web ...

Ted Waller is a private investor who bought his first stock at age 13 (GTE) and has over 55 years of investing experience. His focus is on value and favorable risk/reward ratio, and special situations. Acquiring wealth is an incremental process that requires setting goals, adherence to principles, and patience.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the pu ...

根据出行平台数据预测，今年暑期，避暑游、毕业游、亲子研学游增长最为突出，预订量持续走高。与 往年一样，亲子出行依然是暑运出行主力，预计占比超三成。 近期，杭州机场恢复马来西亚沙巴、印度尼西亚雅加达航线，同时加密"新马泰"航班。热门的日本、韩 国方向，恢复了日本冲绳、名古屋直飞航线，日韩航线日均出港都在6班次以上。此外，持续加密香 港、澳门等地区航线航班，地区航班每日增加至15班，便利暑期探亲及旅游客流。 值得关注的是，今年暑期，出境游新兴市场表现亮眼，迪拜、多哈、阿拉木图、塔什干航班量同比去年 增长超80%。洲际航线方面，随着长线旅游市场逐步回暖，罗马、马德里、开罗、悉尼等目的地客流量 将大幅提升，预计环比暑运前增长近二成。 杭州机场重点加密西北、东北、西南及沿海区域航班。如旅客青睐的青岛、贵阳、长春、昆明等"清凉 避暑"航线，日均增加4班以上；西安、乌鲁木齐、成都等"网红城市"航班量，同比增长近二成，并且首 次开通伊宁、敦煌暑期直飞航线。 据悉，中国国际航空公司于7月1日起正式开通"杭州—敦煌"直飞航线，单程飞行时间约4小时10分钟， 为两地文化交流、旅游发展与经贸往来注入新活力。 暑期出境游市场也进一步升 ...

中国稀土集团回应 2025 年 6 月 29 日，中国稀土集团发布了一则严正声明，把近期互联网上甚嚣尘上的一则谣言击得粉 碎。此前，网络上流传着这样的说法：中国稀土集团的高管层以及掌握核心技术的人员，离职后纷纷被 西方国家或国外企业高薪挖走，远走海外就职。 | CHINA RARE EARTH GROUP | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 首页 集团概况 | 新闻中心 | 企业党建 | 集团业务 | 科技创新 | 社会责任 | 人力资源 | 伯恩公开 | 专题专栏 | O Z Z A | | BBAIE < 04004 < KB | | | | | | | | | | | 高明 | | | | | | | | | | | & 6010) 2025 06-29 12:27:34 | | | | | | | | | BA A | | 针对近界石洞区足ら的中国际土壤周和船台国《以下简称"中国相土资阳"》据下上市公司"中国际民主"（000051.52）移分直属。高荣职业绩方面的不完信息 ...

中新网南宁7月1日电 (莫育杰宋依洁封荣权)中国铁路南宁局集团有限公司(下称：国铁南宁局)1日介 绍，6月30日，一列载着130吨化肥的货物列车从广西南宁始发，经南昆铁路运抵云南昆明中转后，这批 货物将衔接昆明市王家营西至磨憨境中亚国际班列开行，通过中老铁路发往老挝万象，全程运输时效大 幅压缩，为广西货物出口提供方便快捷的运输保障。 近年来，广西物流企业在开拓国际市场时注意到，海外客户对可靠的物流运输非常重视，稳定的物流通 道对跨境贸易意义重大。铁路运量大、运输稳定，能更好地满足跨境货物运输需求。 当前，广西的汽车、机械设备、钢材等受到老挝客户的青睐；老挝的钾肥、铜矿、铁矿、水果等在广西 也很有市场。广西物流企业计划通过"南宁—万象"全程铁路运输促进两地贸易往来。(完) "原来广西的货物要先从防城港到越南，从越南再到老挝，整个时长是8天至10天，现在走铁路专列，从 广西到老挝时长只用3天，大幅提升了我们的运输效率。"广西桂物物流服务集团有限公司总经理廖东富 说。 据了解，随着"一带一路"倡议深入实施和RCEP(区域全面经济伙伴关系协定)红利持续释放，中国与东 盟国家间的经贸往来更加密切。2022年4月初，广西 ...

本文基于以下微博话题的智搜结果生成 关于2025年底金价能否涨至每盎司3500美元的问题，综合市场动态、机构观点及影响因素分析如下： 一、支持涨至3500美元的核心依据 主流投行看涨预期 高盛与瑞银：2025年4-5月多次上调预测，认为地缘风险（特朗普关税政策、中东冲突）、美元信用弱 化及央行持续购金将推动金价在年底达到3700美元/盎司，甚至2026年中期上看4000美元。 南华期货：中长期上涨周期未结束，黄金调整后仍可能上探3700美元，央行购金托底效应显著。 政策与避险双驱动 美联储降息预期：若9月降息落地（受特朗普施压及经济数据影响），美元进一步疲软（美元指数已跌 至2022年3月以来新低）将提振金价。 地缘风险反复：中东停火协议脆弱性、中美关税谈判反复可能重新激发避险需求。 结构性需求支撑 央行购金常态化：全球央行连续16年净买入（2025年一季度增储244吨），95%央行计划未来12个月继 续增持黄金。 ⚠️ 二、阻碍涨势的关键风险 技术面回调压力 关键支撑位失守：花旗警告若金价跌破3165美元/盎司，可能触发10-15%技术性回调（目标区间2500- 2700美元）。 高位泡沫风险：当前金价已脱 ...

暑运期间，国铁太原局各高铁线路按照高峰图运输模式加大运力投放，增开动车组临时旅客列车48列， 首次开行太原南往返深圳北的夕发朝至动卧列车，北京丰台往返成都东、贵阳北的动卧列车经太原站运 行，增开太原南往返青岛北夜间动车组列车。 中新网太原7月1日电 (任丽娜)记者从铁路部门获悉，2025年暑运于7月1日启动至8月31日结束，为期62 天。国铁太原局预计发送旅客1705万人次，日均27.5万人次，同比增长6%。期间，国铁太原局计划增 开旅客列车67列，最大限度满足旅客出行需求。 铁路部门提醒，暑运期间增开列车详情请以车站公告和中国铁路客户服务中心12306网站公布为准，旅 客可通过以上方式查询旅客列车动态信息，以便合理安排行程。(完) 根据预测，今年暑运客流以旅游、探亲、研学等为主，7月下旬至8月中下旬客流将持续处于高位运行， 整体呈现两头低、中间高，周末客流大于周中客流的特点。客流主要集中在北京、天津、沈阳、上海、 广州、西安、成都、重庆、武汉、郑州等中心城市和苏州、青岛、秦皇岛等旅游目的地以及省内太原、 大同、运城、长治、晋城等地。 暑运期间，增开普速临时旅客列车19列，其中首次开行太原往返西宁旅客列车，为 ...

What Happened? LOS ANGELES, July 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 11, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) securities between February 27, 2025 and May 26, 2025, inclusive (the "Class Period"). IF YOU SUFFERED A LOSS ON YOUR ROCKET INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIA ...

Core Viewpoint - 3D Systems Corporation is facing a class action lawsuit due to significant financial losses and misleading statements made by the company regarding its business performance and outlook during the Class Period from August 13, 2024, to May 12, 2025 [1][5]. Financial Performance - On March 26, 2025, 3D Systems reported its Q4 and full-year 2024 results, missing consensus estimates for non-GAAP earnings-per-share and sales revenue, attributing the shortfall to lower hardware systems sales caused by macroeconomic factors [2]. - The company experienced a revenue reduction of $9 million in Q4 due to changes in accounting estimates related to its Regenerative Medicine program [2]. - Following this announcement, the stock price dropped by $0.57, or 21%, closing at $2.15 per share on March 27, 2025 [2]. - On May 12, 2025, 3D Systems released its Q1 2025 results, again missing estimates, primarily due to a decline in material sales linked to inventory management issues in its Healthcare Solutions segment [3]. - The company withdrew its full-year 2025 outlook, citing ongoing softness in customer capital spending and macroeconomic uncertainty [3]. - The stock price fell further by $0.68, or 26.6%, closing at $1.87 per share on May 13, 2025 [4]. Lawsuit Details - The class action lawsuit alleges that 3D Systems made materially false and misleading statements and failed to disclose adverse facts about its business and prospects during the Class Period [5]. - Specific allegations include the understatement of the impact of weakened customer spending and the overstatement of the company's resilience in challenging conditions [5]. - The lawsuit claims that the updated milestone criteria in the United Partnership negatively affected the revenue from the Regenerative Medicine Program [5].